E

Emergent BioSolutions

2321 employees

Emergent BioSolutions develops, manufactures, and delivers a portfolio of medical countermeasures for biological and chemical threats.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Contract Development and Manufacturing
Life Science
Partnering
M&A
Therapeutics Development
Devices Development
Vaccine Development
Health Care
Manufacturing

Date founded

1998

Funding rounds raised

Total raised

$15M

from 2 investors over 2 rounds

E

Emergent BioSolutions raised undisclosed on November 14, 2022

Investors: united-states-department-of-defense

E

Emergent BioSolutions raised $15M on April 3, 2020

Investors: Biomedical Advanced Research and Development Authority (BARDA)

FAQ